To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.
- Today’s Promising Areas of Cancer Research
- What is Cancer?
- A Broken Pipeline?
A Generation of Science at Risk
- ARISE Report
Early Career Scientists and High-Risk, High Reward Research - American Academy of Arts and Sciences
- Why We’re Losing the War on Cancer (And How To Win It)
Clifton Leaf - Fortune Magazine
September 24, 2009 > New NIH High-Risk Research Awards announced
The NIH announced 115 new High-Risk Research Awards totaling $348 million: 42 Transformative R01 Awards, 18 Pioneer Awards, and 55 New Innovator Awards for early-stage investigators. The intent of these awards is to encourage investigators to explore bold ideas that have the potential to catapult fields forward and speed the translation of research into improved health. We congratulate the Damon Runyon scientists who are recipients of these awards.
Transformative R01 Award:
• Benjamin F. Cravatt, PhD (Fellowship Award Committee Member), The Scripps Research Institute, La Jolla
• Linda G. Griffith, PhD (Innovation Award Committee Member), Massachusetts Institute of Technology, Cambridge
• Muneesh Tewari, MD, PhD (Damon Runyon-Rachleff Innovator ‘09-‘11, Damon Runyon Fellow ‘01), Fred Hutchinson Cancer Research Center, Seattle
• Mark J. Zylka, PhD (Damon Runyon Fellow ‘00-‘03), University of North Carolina, Chapel Hill
Pioneer Award:
• Markus W. Covert, PhD (Damon Runyon Fellow ‘04-‘06), Stanford University, Stanford
New Innovator Award:
• Alla Grishok, PhD (Damon Runyon Fellow ‘02-‘05), Columbia University, New York
• John L. Rinn, PhD (Damon Runyon-Rachleff Innovator ‘09-‘11, Damon Runyon Fellow ‘05-‘07), Broad Institute of MIT and Harvard, Boston
• Pardis C. Sabeti, MD, PhD (Damon Runyon Fellow ‘04-‘06), Harvard University, Cambridge
• Wenying Shou, PhD (Damon Runyon Fellow ‘02-‘05), Fred Hutchinson Cancer Research Center, Seattle